abstract |
The present invention provides a method for predicting an individual's predisposition to suffering from Parkinson's disease (PD) on the basis of a blood sample isolated from said individual. Said method comprises combined use of 36 novel SNPs with the ability to pre-clinically predict the appearance of PD complex. Furthermore, the present invention provides a method that comprises the use of a digenic combination of SNPs from the SIL1 × Chr6 loci, which confers on carriers thereof a greater risk of suffering from Parkinson's disease. |